These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 54725)

  • 1. Letter: Hepatitis-B immunoglobulin in prevention of HBs antigenaemia in haemodialysis patients.
    Delons S; Kleinknecht D; Courouce AM
    Lancet; 1976 Jan; 1(7952):204-5. PubMed ID: 54725
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis-B immunoglobulin in prevention of HBs antigenaemia in haemodialysis patients.
    Desmyter J; Bradburne AF; Vermylen C; Daneels R; Boelaert J
    Lancet; 1975 Aug; 2(7931):376-7. PubMed ID: 51188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter: Effectiveness of hepatitis-B immune globulin in haemodialysis patients.
    Szmuness W; Prince AM; Hoofnagle JH; Ribot S; Jacobs MJ
    Lancet; 1974 Dec; 2(7895):1512-3. PubMed ID: 4140421
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: HL-A 1,8 phenotype and HBs antigenaemia in haemodialysis patients.
    Bach JF; Zingraff J; Descamps B; Naret C; Jungers P
    Lancet; 1975 Oct; 2(7937):707. PubMed ID: 52078
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis B "immune" globulin: effectiveness in prevention of dialysis-associated hepatitis.
    Prince AM; Szmuness W; Mann MK; Vyas GN; Grady GF; Shapiro FL; Suki WN; Friedman EA; Stenzel KH
    N Engl J Med; 1975 Nov; 293(21):1063-7. PubMed ID: 1101066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials of hepatitis B immune globulin. Development of policies and materials for the 1972-1975 studies sponsored by the National Heart and Lung Institute.
    Surgenor DM; Chalmers TC; Conrad ME; Friedewald WT; Grady GF; Hamilton M; Mosley JW; Prince AM; Stengle JM
    N Engl J Med; 1975 Nov; 293(21):1060-2. PubMed ID: 1178022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Statistical analysis on the effect of the intravenous immunoglobulin prevention of transfusion hepatitis].
    Hoppe I; Schmidt K
    Dtsch Med Wochenschr; 1974 May; 99(20):1092-4. PubMed ID: 4834769
    [No Abstract]   [Full Text] [Related]  

  • 8. The prevention of hepatitis in haemodialysis units.
    Polakoff S
    Postgrad Med J; 1971 Jul; 47(549):501-3. PubMed ID: 4997832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis b infection in renal transplant recipients (author's transl)].
    Schmidt P; Zazgornik J; Pesendorfer FX; Kopsa H; Pils P; Wewalka F; Deutsch E
    Wien Klin Wochenschr; 1978 Mar; 90(5):173-6. PubMed ID: 343398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of Australia antigen-positive hepatitis within haemodialysis units.
    Almeida JD
    Proc R Soc Med; 1973 Aug; 66(8):798. PubMed ID: 4733975
    [No Abstract]   [Full Text] [Related]  

  • 11. Viral hepatitis in dialysis units.
    Goldsmith HJ
    Nephron; 1974; 12(5):355-67. PubMed ID: 4824046
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vaccination against hepatitis B in man].
    Maupas P; Goudeau A; Coursaget P; Drucker J; Bagros P; Baudin S
    Nouv Presse Med; 1977 Jan; 6(1):27-31. PubMed ID: 401985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of HBe/anti-HBe system and DNA polymerase activity in chronic hepatitis-B virus carriers on haemodialysis. A prospective study.
    Marchesini G; Zoli M; Angiolini A; Feliciangeli G; Santoro A; Ferroni P; Zanetti AR
    Nephron; 1981; 29(1-2):44-8. PubMed ID: 7329473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B immune globulin--prevention of hepatitis from accidental exposure among medical personnel.
    Grady GF; Lee VA
    N Engl J Med; 1975 Nov; 293(21):1067-70. PubMed ID: 1178023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of hepatitis B in hemodialysis patients using hepatitis B immunoglobulin. A controlled study.
    Kleinknecht D; Courouce AM; Delons S; Naret C; Adhemar JP; Ciancioni C; Fermanian J
    Clin Nephrol; 1977 Sep; 8(3):373-6. PubMed ID: 912951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Can therapeutic measures cause a hepatitis virus infection to become chronic? (author's transl)].
    Müller R
    MMW Munch Med Wochenschr; 1976 May; 118(21):679-82. PubMed ID: 58376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunisation against hepatitis B in man.
    Maupas P; Goudeau A; Coursaget P; Drucker J; Bagros P
    Lancet; 1976 Jun; 1(7974):1367-70. PubMed ID: 59012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B prevalence and immunoprophylaxis with hepatitis B immunoglobulins in patients, relatives, and staff of a paediatric haemodialysis unit.
    Ghio L; Moroni GA; Piccoli P; Trombini M; Giani M; Angeli M; Edefonti A
    Helv Paediatr Acta; 1982; 37(1):17-26. PubMed ID: 7085327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of serum hepatitis in a dialysis unit.
    Bosch E; Kolk-Vegter AJ
    Neth J Med; 1973; 16(4):200-11. PubMed ID: 4750040
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of hepatitis in haemodialysis units.
    D'Amico G; Giangrande A; Sorgato G
    Minerva Nefrol; 1972; 19(1):28-34. PubMed ID: 4681083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.